✦ LIBER ✦

High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia

✍ Scribed by Anne Winkler; Robert W. Jackson; Donald S. Kay; Edith Mitchell; Sharon Carmignani; Gordon C. Sharp

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 266 KB
Volume: 31
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780310518

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of refractory, systemic lupus

Treatment of refractory, systemic lupus erythematosus–associated thrombocytopenia with intermittent low-dose intravenous cyclophosphamide

✍ Barbara A. Roach; Gordon J. Hutchinson 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

lupus patient with severe, treatment-resistant thrombocytopenia, which was successfully treated with lowdose IV bolus cyclophosphamide and prednisone after several other treatments had failed.

High-dose cyclophosphamide versus monthl

High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: A prospective randomized trial

✍ Michelle Petri; Robert A. Brodsky; Richard J. Jones; Douglas Gladstone; Michael 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

High-dose cyclophosphamide in the treatm

High-dose cyclophosphamide in the treatment of severe aplastic anemia in children

✍ José Carlos Jaime-Pérez; Oscar González-Llano; David Gómez-Almaguer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

FL 33612 to permit rapid consideration for publication. ## Mutations in the Factor XI Gene To the Editor: Mutations in the factor XI gene are responsible for a variable bleeding phenotype which correlates poorly with levels of circulating FXI product. We read with interest and concern an article

Treatment of systemic lupus erythematosu

Treatment of systemic lupus erythematosus–associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil

✍ Anil Gehi; Allison Webb; Martha Nolte; John Davis Jr. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immunologic self‐tolerance and the subsequent development of autoantibodies. These antibodies are thought to be important in relation to the clinical manifestations of the disease. One example is the de